{"entity":{"id":"4be7d3a1-b5ee-571b-b209-42f0058c22ae","name":"667, L.P.","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001551139","risk":"MED","flags":[]},"identity":{"linked_records":[{"id":"22684e08-f012-520e-8110-6f4d03c31a58","name":"667, L.P.","jurisdiction":"US","identifier":"lei:549300HX7UPMS6S15O35","registry":"gleif"}],"also_known_in":["gleif"]},"ownership":{"direct_owners":[],"holdings":[{"role":"10% owner","share":null,"asset":{"id":"e833c502-aac4-5f5d-bc9c-03df374f0427","name":"DBV Technologies S.A.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"5a0803a2-bf07-554e-8b32-43d9a7f4d76c","name":"Immunocore Holdings plc","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"2a9e232f-1c55-5a2d-a5ad-a8f772329c57","name":"Replimune Group, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"2a9e232f-1c55-5a2d-a5ad-a8f772329c57","name":"Replimune Group, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"f5578d61-5548-5f21-9025-ed125e4ab7ca","name":"BeiGene, Ltd.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"0acb5729-b5ad-50bb-a9be-f3ce653d4a67","name":"BICYCLE THERAPEUTICS PLC","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"3608c469-3b96-5030-8ce2-c1e229f9225f","name":"IGM Biosciences, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"1226ba5b-bd76-5385-89a8-2c29a8a06fcf","name":"INCYTE CORP","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551139"}],"source":"corpus"}